EU OK for paediatric trials in haematology and neurology
This article was originally published in Scrip
The EMEA's paediatric committee has given the go-ahead to more plans for drug trials in children, although it turned down proposed trial programmes for two combination drug products and instead issued a full waiver.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.